{"id":53487,"date":"2023-01-31T21:00:12","date_gmt":"2023-01-31T20:00:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/"},"modified":"2023-01-31T21:00:12","modified_gmt":"2023-01-31T20:00:12","slug":"radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/","title":{"rendered":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum"},"content":{"rendered":"
\n

SAN FRANCISCO–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx\u00ae), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3rd, 2023 in San Francisco, USA.\n<\/p>\n

<\/a><\/p>\n

\nThe Radiance Therapeutics presentation is part of the \u201cEmerging Glaucoma Devices\u201d session to be moderated by Dr. Sahar Bedrood and Dr. Tom Samuelson.\n<\/p>\n

\nGlaucoma 360 is a series of three days of annual events uniting research, industry, and philanthropy to prevent vision loss from glaucoma. Headlining this event will be the New Horizons Forum which serves as an annual catalyst meeting to bring together the essential stakeholders required to speed the translation of new ideas into clinical practice. The forum will feature presentations, panels, and discussions from CEOs of start-up companies, industry executives, ophthalmic leaders, and venture capitalists, with this year\u2019s theme focusing on speeding the development of new therapies and diagnostics for glaucoma patients.\n<\/p>\n

\nDr. Marsteller will also showcase RadianceTx\u00ae future development plans for its device, which received a FDA 510(k) clearance on January 11, 2023, at the LSI USA \u201923 Emerging Medtech Summit to be held at the Monarch Beach Resort, Dana Point, CA from March 20-23 2023. LSI USA is a unique conference that over 3 days brings together the most innovative emerging medtech players, accredited investors and strategics looking for partnership and investment opportunities.\n<\/p>\n

\nAbout RadianceTx\u00ae\n<\/p>\n

\nRadianceTx\u00ae is a trademark of Radiance Therapeutics, Inc., a Delaware corporation. For more information visit www.radiancetherapeutics.com<\/a>\n<\/p>\n

\nFor additional information about Glaucoma 360 New Horizons 2023, please visit: https:\/\/glaucoma.org\/events\/glaucoma-360<\/a>\n<\/p>\n

\nFor additional information about LSI USA \u201923 Emerging Medtech Summit, please visit: https:\/\/www.lifesciencemarketresearch.com\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor additional information about Radiance Therapeutics and its technology:
\n
Radiance Therapeutics CEO, Laurence Marsteller: L.Marsteller@radiancetx.com<\/a>
Business Development, Mark Mayhew: Mark@emmetropes.com<\/a>
Thomas Masterson, Managing Director, Allele Capital Partners: tmasterson@allelecapital.com<\/a>
Giorgio Pirazzini, GP Communications: giorgio@gpcommunications.eu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx\u00ae), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3rd, 2023 in San Francisco, USA. The Radiance Therapeutics presentation is part … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53487","6":"format-standard","7":"category-industry"},"yoast_head":"\nRadiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx\u00ae), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3rd, 2023 in San Francisco, USA. The Radiance Therapeutics presentation is part ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T20:00:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum\",\"datePublished\":\"2023-01-31T20:00:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/\"},\"wordCount\":332,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230131005970\\\/en\\\/1701320\\\/21\\\/RT_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/\",\"name\":\"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230131005970\\\/en\\\/1701320\\\/21\\\/RT_Logo.jpg\",\"datePublished\":\"2023-01-31T20:00:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230131005970\\\/en\\\/1701320\\\/21\\\/RT_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230131005970\\\/en\\\/1701320\\\/21\\\/RT_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/","og_locale":"en_US","og_type":"article","og_title":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend","og_description":"SAN FRANCISCO–(BUSINESS WIRE)–Radiance Therapeutics, Inc. (RadianceTx\u00ae), an innovation leader in ophthalmic devices, today announced that Dr. Laurence Marsteller, Chief Executive Officer, will present the company at the Glaucoma Research Foundation headline event, Glaucoma 360 New Horizons 2023, that will take place on February 3rd, 2023 in San Francisco, USA. The Radiance Therapeutics presentation is part ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-31T20:00:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum","datePublished":"2023-01-31T20:00:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/"},"wordCount":332,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/","url":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/","name":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg","datePublished":"2023-01-31T20:00:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230131005970\/en\/1701320\/21\/RT_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/radiance-therapeutics-to-present-at-glaucoma-360-new-horizons-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Radiance Therapeutics to Present at Glaucoma 360 New Horizons Forum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53487"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53487\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}